Keck School Faculty

Michael Pulsipher, MD
Michael Pulsipher, MD
Professor of Pediatrics (Clinical Scholar)
Pediatrics
CHLA 4650 W. Sunset Blvd. Off Campus Los Angeles

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia Blood Adv. 2019 Oct 22; 3(20):3123-3131. . View in PubMed

Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT J Clin Immunol. 2019 Oct; 39(7):653-667. . View in PubMed

Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement Biol Blood Marrow Transplant. 2019 Sep; 25(9):1890-1897. . View in PubMed

Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial Lancet Haematol. 2019 Aug; 6(8):e409-e418. . View in PubMed

Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria Blood. 2019 Jul 18; 134(3):304-316. . View in PubMed

Higher Reported Lung Dose Received During Total Body Irradiation for Allogeneic Hematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia Is Associated With Inferior Survival: A Report from the Children's Oncology Group Int J Radiat Oncol Biol Phys. 2019 Jul 01; 104(3):513-521. . View in PubMed

Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results Biol Blood Marrow Transplant. 2019 May; 25(5):955-964. . View in PubMed

Advances in hematopoietic cell transplant for the treatment of hematologic malignancies Curr Opin Pediatr. 2019 Feb; 31(1):3-13. . View in PubMed

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma Haematologica. 2019 Feb; 104(2):380-391. . View in PubMed

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study Biol Blood Marrow Transplant. 2019 04; 25(4):699-711. . View in PubMed

Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients Biol Blood Marrow Transplant. 2019 03; 25(3):556-561. . View in PubMed

Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation Bone Marrow Transplant. 2018 10; 53(10):1278-1287. . View in PubMed

Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis Biol Blood Marrow Transplant. 2018 09; 24(9):1928-1935. . View in PubMed

Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT Biol Blood Marrow Transplant. 2018 07; 24(7):1313-1321. . View in PubMed

Hypogammaglobulinemia due to CAR T-cell therapy Pediatr Blood Cancer. 2018 04; 65(4). . View in PubMed

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia Biol Blood Marrow Transplant. 2018 04; 24(4):726-733. . View in PubMed

Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutationsJ Allergy Clin Immunol. 2018 02; 141(2):704-717. e5. . View in PubMed

Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less Biol Blood Marrow Transplant. 2018 01; 24(1):175-184. . View in PubMed

Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622 J Clin Oncol. 2018 08 01; 36(22):2306-2314. . View in PubMed

Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia Clin Cancer Res. 2018 12 15; 24(24):6175-6184. . View in PubMed

2018 11 30; 2018(1):16-24. . View in PubMed

Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT Biol Blood Marrow Transplant. 2017 Sep; 23(9):1422-1428. . View in PubMed

Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation Biol Blood Marrow Transplant. 2017 May; 23(5):726-735. . View in PubMed

Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation Biol Blood Marrow Transplant. 2017 Apr; 23(4):552-561. . View in PubMed

Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT Biol Blood Marrow Transplant. 2017 Mar; 23(3):379-387. . View in PubMed

CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation Biol Blood Marrow Transplant. 2017 Mar; 23(3):405-411. . View in PubMed

Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children's Oncology Group Haematologica. 2017 09; 102(9):e340-e343. . View in PubMed

Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia Haematologica. 2017 07; 102(7):1291-1298. . View in PubMed

Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study Biol Blood Marrow Transplant. 2017 01; 23(1):165-171. . View in PubMed

Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study Blood. 2017 12 21; 130(25):2718-2727. . View in PubMed

Health-Related Quality of Life among Pediatric Hematopoietic Stem Cell DonorsJ Pediatr. 2016 Nov; 178:164-170. e1. . View in PubMed

European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards Biol Blood Marrow Transplant. 2016 Mar; 22(3):514-9. . View in PubMed

Fishing for complements Blood. 2016 Feb 25; 127(8):957-8. . View in PubMed

Evolving hematopoietic stem cell transplantation strategies in severe aplastic anemia Curr Opin Pediatr. 2016 Feb; 28(1):3-11. . View in PubMed

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies Biol Blood Marrow Transplant. 2016 Feb; 22(2):248-257. . View in PubMed

Long-Term Follow-Up after Reduced-Intensity Conditioning and Stem Cell Transplantation for Childhood Nonmalignant Disorders Biol Blood Marrow Transplant. 2016 08; 22(8):1467-1472. . View in PubMed

A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group Leuk Lymphoma. 2016 07; 57(7):1567-74. . View in PubMed

Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes Biol Blood Marrow Transplant. 2016 07; 22(7):1197-1205. . View in PubMed

A trial of unrelated donor marrow transplantation for children with severe sickle cell disease Blood. 2016 11 24; 128(21):2561-2567. . View in PubMed

Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia J Clin Oncol. 2016 05 01; 34(13):1537-43. . View in PubMed

Deficient Neutrophil Extracellular Trap Formation in Patients Undergoing Bone Marrow Transplantation Front Immunol. 2016; 7:250. . View in PubMed

Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical ConsiderationsRecommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association. Biol Blood Marrow Transplant. 2016 Jan; 22(1):96-103. . View in PubMed

Challenges in the harmonization of immune monitoring studies and trial design for cell-based therapies in the context of hematopoietic cell transplantation for pediatric cancer patients Cytotherapy. 2015 Dec; 17(12):1667-74. . View in PubMed

Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning Cancer. 2015 Oct 15; 121(20):3709-16. . View in PubMed

Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers Biol Blood Marrow Transplant. 2015 Oct; 21(10):1830-8. . View in PubMed

Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study Lancet Haematol. 2015 Sep; 2(9):e367-75. . View in PubMed

IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients Blood. 2015 May 28; 125(22):3501-8. . View in PubMed

Long-term outcomes in MPS-IH: throwing stars Blood. 2015 Mar 26; 125(13):2016-7. . View in PubMed

A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies Bone Marrow Transplant. 2015 Mar; 50(3):334-40. . View in PubMed

Blood and marrow transplant clinical trials network state of the Science Symposium 2014 Biol Blood Marrow Transplant. 2015 Feb; 21(2):202-24. . View in PubMed

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation J Clin Oncol. 2014 Oct 10; 32(29):3249-56. . View in PubMed

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation Haematologica. 2014 Oct; 99(10):1624-31. . View in PubMed

Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiencyJ Allergy Clin Immunol. 2014 Oct; 134(4):935-943. e15. . View in PubMed

Chimerism versus minimal residual disease monitoring after allogeneic transplantation--when do we act and will intervention improve outcomes? Biol Blood Marrow Transplant. 2014 Oct; 20(10):1461-2.. View in PubMed

Haplo is the new black Blood. 2014 Jul 31; 124(5):675-6. . View in PubMed

Allotransplantation for patients age =40 years with non-Hodgkin lymphoma: encouraging progression-free survival Biol Blood Marrow Transplant. 2014 Jul; 20(7):960-8. . View in PubMed

Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation Blood. 2014 May 29; 123(22):3504-11. . View in PubMed

Autoimmunity due to RAG deficiency and estimated disease incidence in RAG1/2 mutationsJ Allergy Clin Immunol. 2014 Mar; 133(3):880-2. e10. . View in PubMed

Exposure of early pediatric trainees to blood and marrow transplantation leads to higher recruitment to the field Biol Blood Marrow Transplant. 2013 Sep; 19(9):1399-402. . View in PubMed

Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial Biol Blood Marrow Transplant. 2013 Sep; 19(9):1340-7. . View in PubMed

Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group Biol Blood Marrow Transplant. 2013 Sep; 19(9):1279-87. . View in PubMed

Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience Bone Marrow Transplant. 2013 Aug; 48(8):1056-64. . View in PubMed

Aplastic Anemia & MDS International Foundation (AA&MDSIF): bone marrow failure disease scientific symposium 2012 Leuk Res. 2013 Jul; 37(7):848-51. . View in PubMed

Better BMT for Hurler syndrome--on the level? Blood. 2013 May 09; 121(19):3785-7.. View in PubMed

Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation J Clin Oncol. 2013 Apr 20; 31(12):1530-8. . View in PubMed

Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program Blood. 2013 Jan 03; 121(1):197-206. . View in PubMed

Children's Oncology Group's 2013 blueprint for research: stem cell transplantation Pediatr Blood Cancer. 2013 06; 60(6):1044-7. . View in PubMed

Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels Biol Blood Marrow Transplant. 2012 Jul; 18(7):1007-11. . View in PubMed

A donor's a person, no matter how small Blood. 2012 Mar 22; 119(12):2705-6. . View in PubMed

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies JAMA. 2011 Nov 02; 306(17):1874-83. . View in PubMed

Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association Haematologica. 2011 Jul; 96(7):942-7. . View in PubMed

High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant? Biol Blood Marrow Transplant. 2011 Jan; 17(1 Suppl):S137-48.. View in PubMed

Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium Biol Blood Marrow Transplant. 2010 Sep; 16(9):1212-21. . View in PubMed

Family donor care management: principles and recommendations Bone Marrow Transplant. 2010 Aug; 45(8):1269-73. . View in PubMed

Allogeneic marrow transplantation in children with acute leukemia: careful comparison with chemotherapy alternatives required Leukemia. 2010 Jun; 24(6):1212-6. . View in PubMed

Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations Bone Marrow Transplant. 2010 May; 45(5):832-8. . View in PubMed

Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial Biol Blood Marrow Transplant. 2010 Mar; 16(3):384-94. . View in PubMed

A phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL) Br J Haematol. 2009 Dec; 147(5):691-9. . View in PubMed

Impact of conditioning regimen in allogeneic hematopoetic stem cell transplantation for children with acute myelogenous leukemia beyond first complete remission: a pediatric blood and marrow transplant consortium (PBMTC) study Biol Blood Marrow Transplant. 2009 Dec; 15(12):1620-7. . View in PubMed

Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose Blood. 2009 Sep 24; 114(13):2606-16. . View in PubMed

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program Blood. 2009 Apr 09; 113(15):3604-11. . View in PubMed

Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting Blood. 2009 Apr 02; 113(14):3383-91. . View in PubMed

Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse Biol Blood Marrow Transplant. 2009 Jan; 15(1 Suppl):62-71. . View in PubMed

Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma Biol Blood Marrow Transplant. 2008 Nov; 14(11):1279-87. . View in PubMed

Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning J Clin Oncol. 2008 Oct 20; 26(30):4912-20. . View in PubMed

Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population Bone Marrow Transplant. 2008 Aug; 42(3):201-5. . View in PubMed

Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation Cancer. 2008 May 01; 112(9):1992-2001. . View in PubMed

A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study Blood. 2007 Dec 15; 110(13):4584-7. . View in PubMed

Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders Bone Marrow Transplant. 2007 Oct; 40(7):633-42. . View in PubMed

Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning Biol Blood Marrow Transplant. 2007 Sep; 13(9):1041-8. . View in PubMed

Incidence, risk factors, and pathogenesis of second malignancies in patients with non-Hodgkin lymphoma Leuk Lymphoma. 2007 Aug; 48(8):1482-95. . View in PubMed

Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria Blood. 2007 Mar 15; 109(6):2618-21. . View in PubMed

Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation J Clin Oncol. 2006 Sep 01; 24(25):4150-7. . View in PubMed

High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update J Clin Oncol. 2006 Jun 20; 24(18):2891-6. . View in PubMed

Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months J Clin Oncol. 2006 Jan 01; 24(1):145-51. . View in PubMed

Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia J Clin Oncol. 2005 Jun 01; 23(16):3819-29. . View in PubMed

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia Biol Blood Marrow Transplant. 2005 Apr; 11(4):272-9. . View in PubMed

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma Blood. 2004 Dec 01; 104(12):3535-42. . View in PubMed

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies Blood. 2003 Sep 15; 102(6):2021-30. . View in PubMed

Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant Biol Blood Marrow Transplant. 2003 Apr; 9(4):266-72. . View in PubMed

Powered by SC CTSI
Go to Top